Skip to main content
Back
Watch Compare

Hepion Pharmaceuticals, Inc.

Data quality: 83%
Also listed as CTRVP OTC
HEPA
OTC Manufacturing Chemicals
$0.05
▼ $0.01 (-13.46%)
Mkt Cap: 522,914.0
Price
$0.05
Mkt Cap
522,914.0
Day Range
$0.05 — $0.05
52-Week Range
$0.03 — $0.62
Volume
24
Open $0.05
50D / 200D Avg
$0.05
7.02% below
50D / 200D Avg
$0.06
25.86% below

Quick Summary

Key Takeaways

Negative free cash flow of -3.27 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-232.48%
Below sector avg (-53.47%)
ROIC-90.05%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio10.77
Interest CoverageN/A

Valuation

PE (TTM)
-0.06
Above sector avg (-1.47)
P/B Ratio0.16
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.1 -1.5
P/B 0.2 1.6
ROE % -232.5 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -8.28 M
ROE -232.48% ROA -200.78%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -3.27 M
ROIC -90.05% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 10.77
Interest Coverage N/A Asset Turnover N/A
Working Capital 3.39 M Tangible Book Value 3.32 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.06 Forward P/E N/A
P/B Ratio 0.16 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -625.63%
Market Cap 522,914.0 Enterprise Value 522,914.0
Per Share
EPS (Diluted TTM) -0.88 Revenue / Share N/A
FCF / Share -0.28 OCF / Share -0.28
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 39.52%
SBC-Adj. FCF -3.32 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — 0.0 0.0 0.0
Net Income -8.28 M -13.19 M -48.93 M -42.20 M -32.72 M
EPS (Diluted) -0.88 -107.35 -12.32 -0.59 -0.47
Gross Profit — — — — —
Operating Income -4.16 M -19.35 M -48.45 M -45.49 M -30.40 M
EBITDA — — — — —
R&D Expenses 445,512.0 11.85 M 35.64 M 33.27 M 20.40 M
SG&A Expenses — — — — —
D&A 30,758.0 30,758.0 67,131.0 77,461.0 86,073.0
Interest Expense — — 9,465.0 10,164.0 8,859.0
Income Tax -2.97 M -2.97 M -409,022.0 -2.88 M 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3.07 M 1.61 M 18.09 M 60.24 M 103.55 M
Total Liabilities 402,405.0 3.48 M 10.81 M 10.39 M 10.56 M
Shareholders' Equity 2.67 M -1.86 M 7.28 M 49.86 M 93.00 M
Total Debt — — — — —
Cash & Equivalents — — — — —
Current Assets 3.07 M 1.61 M 17.49 M 56.50 M 97.45 M
Current Liabilities 299,383.0 3.14 M 5.29 M 7.89 M 8.21 M